Keyphrases
Prothrombin Time
100%
Telavancin
100%
International Normalized Ratio
88%
Coagulation
22%
Clinical Significance
11%
Acquired Resistance
11%
Orthopedic Surgeons
11%
Methicillin-resistant Staphylococcus Aureus Infection
11%
Staphylococcus Aureus
11%
Phospholipids
11%
Difficult-to-treat
11%
Spinal Surgery
11%
New Antibiotics
11%
Actual Effect
11%
In Vitro Testing
11%
Prescribers
11%
Preoperative Testing
11%
Surgery Risk
11%
Medication History
11%
Laboratory Confirmation
11%
Spinal Abscess
11%
Nursing and Health Professions
Infection
100%
Prothrombin Time
100%
Telavancin
100%
International Normalized Ratio
88%
Spine Surgery
11%
Literature Review
11%
Methicillin Resistant Staphylococcus Aureus Infection
11%
Orthopedic Surgeon
11%
Abscess
11%
Phospholipid
11%
Medicine and Dentistry
Infection
100%
Prothrombin Time
100%
Telavancin
100%
In Vitro
11%
Abscess
11%
Orthopedic Surgeon
11%
Staphylococcus Aureus
11%
Spine Surgery
11%
Phospholipid
11%
Methicillin Resistant Staphylococcus Aureus Infection
11%
Preoperative Testing
11%
Pharmacology, Toxicology and Pharmaceutical Science
Infection
100%
Prothrombin
100%
Telavancin
100%
Phospholipid
11%
Staphylococcus Aureus
11%
Abscess
11%
Methicillin Resistant Staphylococcus Aureus Infection
11%
Immunology and Microbiology
Infection
100%
Methicillin-Resistant Staphylococcus Aureus
50%
Staphylococcus Aureus
50%
Abscess
50%
In Vitro
50%